Fig. 6.
Enhancement of ADI-PEG20's antitumor activity by Ly294002 in the tumor xenografts. (A) Inhibition of tumor growth in the ADI-PEG20-, Ly294002-, and combination of ADI-PEG20+Ly294002-treated group as compared with the PBS-treated group; and (B) representative tumor sizes in animals from the four different treated groups.